Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis



Status:Recruiting
Conditions:Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:2/28/2019
Start Date:September 2002
End Date:December 2019
Contact:Han W Kim, MD
Email:kim00050@duke.edu
Phone:919-668-3539

Use our guide to learn which trials are right for you!

Detection and Prognostic Significance of Myocardial Damage Visualized by Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis

The primary objective of this study was to determine the ability of cardiac magnetic
resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were
to undergo CMR in addition to routine clinical evaluation.

In patients with sarcoidosis, cardiac death is a leading cause of mortality which may
represent unrecognized cardiac involvement. Cardiovascular magnetic resonance (CMR) can
detect cardiac involvement including minute amounts of myocardial damage. Therefore, the
objective of this study was to determine the usefulness of CMR and compare it with standard
clinical evaluation for cardiac involvement. Patients with documented extracardiac
sarcoidosis or clinically suspected cardiac sarcoidosis will be enrolled.

Inclusion Criteria:

- Biopsy proven sarcoidosis

- Suspected cardiac sarcoidosis

Exclusion Criteria:

- Contraindication to MRI
We found this trial at
1
site
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Raymond J Kim, MD
Phone: 919-668-3539
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials